Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...

The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of ...

CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated in an ...

Counterpart Health, Inc., a subsidiary of Clover Health, released research indicating that its AI-powered platform, Counterpart Assistant (CA), significantly improves the management of congestive ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Study is Expected to Be One of the Largest Therapeutic Cardiac Device Trials in Heart Failure Ever Performed, and is ...

Panelists discuss their excitement about the evolution of heart failure as a distinct specialty with multiple effective therapeutic options, the convergence of previously siloed medical disciplines ...

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...